Nanotechnology for Treatment of Glioblastoma Multiforme

Glioblastoma multiforme (GBM), a grade IV astrocytoma as defined by the World Health Organization (WHO) criteria, is the most common primary central nervous system tumor in adults. After treatment with the current standard of care consisting of surgical resection, concurrent temozolomide (TMZ), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Michael, Justin S., Lee, Bong-Seop, Zhang, Miqin, Yu, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231306/
https://www.ncbi.nlm.nih.gov/pubmed/30425948
http://dx.doi.org/10.2478/jtim-2018-0025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231306/
https://www.ncbi.nlm.nih.gov/pubmed/30425948
http://dx.doi.org/10.2478/jtim-2018-0025

Ejemplares similares